Company
Johnson Johnson Surgical Vision
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
7
510(k), De Novo and PMA
Device trials
31
As lead sponsor, any status
Adverse event reports
174
Received Nov 1, 2025 to Nov 20, 2026
Recall records
18
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Johnson Johnson Surgical Vision, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
No 5%+ shareholder filings, SBIR grants or venture investors found under the name Johnson Johnson Surgical Vision.
Latest FDA decisions
- TECNIS PureSee IOL, Model DEN00V TECNIS PureSee Toric II IOLs, Model DET150, DET225, DET300, DET375PMA supplement
P980040-S176 · Decided Mar 11, 2026 · 223 days after receipt · Panel Track
Device type: intraocular lens (HQL) · Ophthalmology
6 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Clinical Investigation of the TECNIS® Next-Generation Intraocular LensPivotal-lookingCompleted
NCT06377514 · 245 participants · Start Jun 3, 2024 · Primary completion Apr 23, 2025
Device: Test IOL Model DEN00V; Control IOL Model DCB00 · For: Cataracts
Sites: Bakersfield, California; Jacksonville, Florida; Sioux City, Iowa · 9 sites in all
30 more trials with a free account
Reports received
174
Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.
Malfunction reports
81
47% of reports
Injury reports
92
53% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 3 | 2 | 0 | 1 |
| Jan 24 | 11 | 4 | 0 | 0 |
| Feb 24 | 1 | 1 | 0 | 0 |
| Mar 24 | 163 | 11 | 0 | 0 |
| Apr 24 | 10 | 7 | 0 | 0 |
| May 24 | 4 | 3 | 0 | 0 |
| Jun 24 | 7 | 2 | 0 | 0 |
| Jul 24 | 10 | 7 | 0 | 0 |
| Aug 24 | 7 | 2 | 0 | 0 |
| Sep 24 | 5 | 4 | 0 | 0 |
| Oct 24 | 8 | 4 | 0 | 0 |
| Nov 24 | 2 | 5 | 0 | 0 |
| Dec 24 | 2 | 5 | 0 | 0 |
| Jan 25 | 9 | 1 | 0 | 0 |
| Feb 25 | 8 | 12 | 0 | 0 |
| Mar 25 | 2 | 3 | 0 | 0 |
| Apr 25 | 11 | 6 | 0 | 0 |
| May 25 | 3 | 4 | 0 | 0 |
| Jun 25 | 6 | 8 | 0 | 0 |
| Jul 25 | 7 | 4 | 0 | 0 |
| Aug 25 | 2 | 19 | 0 | 0 |
| Sep 25 | 2 | 1 | 0 | 0 |
| Oct 25 | 10 | 13 | 0 | 1 |
| Nov 25 | 2 | 3 | 0 | 0 |
| Dec 25 | 2 | 5 | 0 | 0 |
| Jan 26 | 8 | 5 | 0 | 0 |
| Feb 26 | 1 | 2 | 0 | 0 |
| Mar 26 | 4 | 3 | 0 | 0 |
| Apr 26 | 11 | 18 | 0 | 0 |
| May 26 | 7 | 10 | 0 | 0 |
| Jun 26 | 11 | 12 | 0 | 0 |
| Jul 26 | 8 | 5 | 0 | 0 |
| Aug 26 | 5 | 11 | 0 | 1 |
| Sep 26 | 12 | 8 | 0 | 0 |
| Oct 26 | 10 | 10 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
5 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3064-2026 · Started Jul 31, 2026 · Posted by FDA Aug 31, 2026
Reason given: Surgical instructions sent for viscoelastic products used during ophthalmic viscosurgical cataract procedures including in part: If resistance is encountered during insertion, withdraw cannula and reassess the insertion conditions (i.e. insertion angle, incision size, etc.) before proceeding because forcing the...
Cause as FDA categorized it: Device Design · Device type: Aid, Surgical, Viscoelastic (LZP)
17 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.